The role of galectins in colorectal cancer progression

International Journal of Cancer

Volumn 129, Issue 1, 2011, Pages 1-8

  Barrow, Hannah ^a   Rhodes, Jonathan M ^a   Yu, Lu Gang ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

cancer progression; colon cancer; galectin; metastasis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BASIC FIBROBLAST GROWTH FACTOR; BETA1 INTEGRIN; BETA1,6 ACETYLGLUCOSAMINYLTRANSFERASE; CASPASE 8; CD45 ANTIGEN; CD7 ANTIGEN; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; GALACTOSE BETA1,3 N ACETYLGALACTOSAMINE ALPHA; GALECTIN 1; GALECTIN 3; GALECTIN 4; GALECTIN 8; LEUKOSIALIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MICROSOMAL AMINOPEPTIDASE; MODIFIED CITRUS PECTIN; MUCIN 1; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PECTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; COLON; COLORECTAL CANCER; GENE OVEREXPRESSION; HUMAN; METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECTUM; REVIEW; TISSUE DISTRIBUTION; TUMOR VASCULARIZATION;

APOPTOSIS; CELL ADHESION; CELL DIVISION; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GALECTINS; HUMANS; NEOPLASM METASTASIS; RECTUM;

EID: 79955481307     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25945     Document Type: Review

References (84)

1. Barondes SH, Cooper DN, Gitt MA, Leffler H,. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807-10.
2. Fred Brewer C,. Binding and cross-linking properties of galectins. Biochim Biophys Acta 2002; 1572: 255-62. (Pubitemid 35246348)
3. Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, Decaestecker C, Salmon I,. The galectin family and digestive disease. J Pathol 2008; 215: 1-12. (Pubitemid 351619870)
4. Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den Brule F, Liu FT, Cardesa A, Campo E,. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997; 113: 1906-15. (Pubitemid 27512149)
5. Huflejt ME, Leffler H,. Galectin-4 in normal tissues and cancer. Glycoconj J 2004; 20: 247-55. (Pubitemid 39090671)
6. Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector JC, Zick Y, Salmon I, et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 2002; 50: 392-401. (Pubitemid 34161058)
7. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M,. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 1999; 15: 143-8.
8. Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL, Lotan R,. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991; 51: 387-93.
9. Lee EC, Woo HJ, Korzelius CA, Steele GD, Jr, Mercurio AM,. Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma. Arch Surg 1991; 126: 1498-502.
10. Iurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S,. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 2000; 6: 1389-93. (Pubitemid 30226225)
11. Nagy N, Legendre H, Engels O, Andre S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius HJ, Salmon I, Kiss R,. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 2003; 97: 1849-58. (Pubitemid 36397258)
12. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, Gabius HJ, Kiss R, Camby I,. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 2003; 103: 370-9. (Pubitemid 36076430)
13. Hubert M, Wang SY, Wang JL, Seve AP, Hubert J,. Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy. Exp Cell Res 1995; 220: 397-406.
14. Fakan S, Puvion E, Sphor G,. Localization and characterization of newly synthesized nuclear RNA in isolate rat hepatocytes. Exp Cell Res 1976; 99: 155-64.
15. Zhang G, Taneja KL, Singer RH, Green MR,. Localization of pre-mRNA splicing in mammalian nuclei. Nature 1994; 372: 809-12.
16. Endo K, Kohnoe S, Tsujita E, Watanabe A, Nakashima H, Baba H, Maehara Y,. Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res 2005; 25: 3117-21.
17. Zaia Povegliano L, Oshima CT, de Oliveira Lima F, Andrade Scherholz PL, Manoukian Forones N,. Immunoexpression of Galectin-3 in colorectal cancer and its relationship with survival. J Gastrointest Cancer, 2010 Jul 16. [Epub ahead of print].
18. Ohannesian DW, Lotan D, Lotan R,. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Cancer Res 1994; 54: 5992-6000. (Pubitemid 24375239)
19. Schoeppner HL, Raz A, Ho SB, Bresalier RS,. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 1995; 75: 2818-26.
20. Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius HJ,. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J Cancer Res Clin Oncol 1999; 125: 461-74. (Pubitemid 29410410)
21. Lahm H, Andre S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ,. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 2001; 127: 375-86. (Pubitemid 32453680)
22. Huflejt ME, Jordan ET, Gitt MA, Barondes SH, Leffler H,. Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. Galectin-4 is localized at sites of cell adhesion. J Biol Chem 1997; 272: 14294-303. (Pubitemid 27232843)
23. Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB,. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci USA 1996; 93: 7252-7. (Pubitemid 26243535)
24. Gopalkrishnan RV, Roberts T, Tuli S, Kang D, Christiansen KA, Fisher PB,. Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene. Oncogene 2000; 19: 4405-16.
25. Horiguchi N, Arimoto K, Mizutani A, Endo-Ichikawa Y, Nakada H, Taketani S,. Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells. J Biochem 2003; 134: 869-74. (Pubitemid 38248362)
26. Kovacs-Solyom F, Blasko A, Fajka-Boja R, Katona RL, Vegh L, Novak J, Szebeni GJ, Krenacs L, Uher F, Tubak V, Kiss R, Monostori E,. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 2010; 127: 108-18.
27. He J, Baum LG,. Presentation of galectin-1 by extracellular matrix triggers T cell death. J Biol Chem 2004; 279: 4705-12. (Pubitemid 38199064)
28. Valenzuela HF, Pace KE, Cabrera PV, White R, Porvari K, Kaija H, Vihko P, Baum LG,. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res 2007; 67: 6155-62. (Pubitemid 47037496)
29. Perillo NL, Pace KE, Seilhamer JJ, Baum LG,. Apoptosis of T cells mediated by galectin-1. Nature 1995; 378: 736-9. (Pubitemid 126647279)
30. Pace KE, Lee C, Stewart PL, Baum LG,. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 1999; 163: 3801-11. (Pubitemid 29450905)
31. Matarrese P, Tinari A, Mormone E, Bianco GA, Toscano MA, Ascione B, Rabinovich GA, Malorni W,. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem 2005; 280: 6969-85. (Pubitemid 40341253)
32. Hernandez JD, Nguyen JT, He J, Wang W, Ardman B, Green JM, Fukuda M, Baum LG,. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J Immunol 2006; 177: 5328-36. (Pubitemid 44527605)
33. Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM,. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. Cell Death Differ 2000; 7: 747-53. (Pubitemid 30599255)
34. Hahn HP, Pang M, He J, Hernandez JD, Yang RY, Li LY, Wang X, Liu FT, Baum LG,. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ 2004; 11: 1277-86. (Pubitemid 39591773)
35. Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A,. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 1997; 57: 5272-6. (Pubitemid 27516362)
36. Yu F, Finley RL, Jr, Raz A, Kim HR,. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 2002; 277: 15819-27. (Pubitemid 34967860)
37. Fukumori T, Takenaka Y, Oka N, Yoshii T, Hogan V, Inohara H, Kanayama HO, Kim HR, Raz A,. Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res 2004; 64: 3376-9. (Pubitemid 38657907)
38. Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS,. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 2000; 275: 36311-5.
39. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A,. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002; 277: 6852-7. (Pubitemid 34953068)
40. Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J,. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 2000; 10: 131-40. (Pubitemid 30193013)
41. Earl LA, Bi S, Baum LG,. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J Biol Chem 2010; 285: 2232-44.
42. Moiseeva EP, Williams B, Samani NJ,. Galectin 1 inhibits incorporation of vitronectin and chondroitin sulfate B into the extracellular matrix of human vascular smooth muscle cells. Biochim Biophys Acta 2003; 1619: 125-32. (Pubitemid 36078348)
43. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL,. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 2008; 27: 3746-53. (Pubitemid 351912963)
44. Elad-Sfadia G, Haklai R, Balan E, Kloog Y,. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 2004; 279: 34922-30. (Pubitemid 39318128)
45. Zhao Q, Guo X, Nash GB, Stone PC, Hilkens J, Rhodes JM, Yu LG,. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res 2009; 69: 6799-806.
46. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K, Rhodes JM,. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007; 282: 773-81. (Pubitemid 47076627)
47. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, Baum LG,. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 2006; 176: 778-89. (Pubitemid 43099674)
48. Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius HJ, Lotan R,. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 1995; 55: 2191-9.
49. Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, Nabi IR,. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol 2006; 26: 3181-93.
50. Yang E, Shim JS, Woo HJ, Kim KW, Kwon HJ,. Aminopeptidase N/CD13 induces angiogenesis through interactionwith a pro-angiogenic protein, galectin-3. Biochem Biophys Res Commun 2007; 363: 336-41. (Pubitemid 47484337)
51. Inohara H, Akahani S, Koths K, Raz A,. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res 1996; 56: 4530-4. (Pubitemid 26330466)
52. Greco C, Vona R, Cosimelli M, Matarrese P, Straface E, Scordati P, Giannarelli D, Casale V, Assisi D, Mottolese M, Moles A, Malorni W,. Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions. Glycobiology 2004; 14: 783-92. (Pubitemid 39206881)
53. Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, Hawke D, Half E, Liu KF, Mazurek N,. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology 2004; 127: 741-8. (Pubitemid 39208407)
54. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW,. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004; 306: 120-4. (Pubitemid 39451953)
55. Ideo H, Seko A, Yamashita K,. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem 2005; 280: 4730-7. (Pubitemid 40288643)
56. Ideo H, Seko A, Ohkura T, Matta KL, Yamashita K,. High-affinity binding of recombinant human galectin-4 to SO(3) (-) - >3Galbeta1 - >3GalNAc pyranoside. Glycobiology 2002; 12: 199-208. (Pubitemid 34567866)
57. Satelli A, Rao PS, Thirumala S, Rao US,. Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer, 2010 Nov 9. [Epub ahead of print].
58. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y,. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 2000; 113 (Part 13): 2385-97. (Pubitemid 30599342)
59. Moiseeva EP, Spring EL, Baron JH, de Bono DP,. Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix. J Vasc Res 1999; 36: 47-58. (Pubitemid 29106806)
60. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 2006; 103: 15975-80. (Pubitemid 44657577)
61. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, Griffioen AW,. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 2010; 70: 6216-24.
62. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A,. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000; 156: 899-909. (Pubitemid 30626949)
63. Markowska AI, Liu FT, Panjwani N,. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med 2010; 207: 1981-93.
64. Cardenas Delgado VM, Nugnes LG, Colombo LL, Troncoso MF, Fernandez MM, Malchiodi EL, Frahm I, Croci DO, Compagno D, Rabinovich GA, Wolfenstein-Todel C, Elola MT,. Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8. FASEB J, 2011;25:242-54.
65. Takenaka Y, Fukumori T, Raz A,. Galectin-3 and metastasis. Glycoconj J 2004; 19: 543-9. (Pubitemid 38316528)
66. Califice S, Castronovo V, Van Den Brule F,. Galectin-3 and cancer (Review). Int J Oncol 2004; 25: 983-92.
67. Rabinovich GA, Toscano MA, Jackson SS, Vasta GR,. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol 2007; 17: 513-20. (Pubitemid 350019014)
68. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A,. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology 1998; 115: 287-96. (Pubitemid 28363421)
69. Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schuring MP, Salmon I, Gabius HJ, Pector JC, Kiss R,. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol 2003; 16: 491-504. (Pubitemid 36618470)
70. Arfaoui-Toumi A, Kria-Ben Mahmoud L, Ben Hmida M, Khalfallah MT, Regaya-Mzabi S, Bouraoui S,. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients). Bull Cancer 2010; 97: E1-E8.
71. Yu LG,. Circulating galectin-3 in the bloodstream: an emerging promoter of cancer metastasis. World J Gastrointest Oncol 2010; 2: 177-80.
72. Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM, Yu LG,. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumor cell homotypic aggregation and prevents anoikis. Mol Cancer 2010; 9: 154.
73. Ishizuka I,. Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 1997; 36: 245-319. (Pubitemid 28132555)
74. Colnot C, Ripoche MA, Milon G, Montagutelli X, Crocker PR, Poirier F,. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology 1998; 94: 290-6. (Pubitemid 28318591)
75. Leffler H, Barondes SH,. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides. J Biol Chem 1986; 261: 10119-26. (Pubitemid 17221945)
76. Ahmed H, Bianchet MA, Amzel LM, Hirabayashi J, Kasai K, Giga-Hama Y, Tohda H, Vasta GR,. Novel carbohydrate specificity of the 16-kDa galectin from Caenorhabditis elegans: binding to blood group precursor oligosaccharides (type 1, type 2, Talpha, and Tbeta) and gangliosides. Glycobiology 2002; 12: 451-61.
77. Beuth J, Ko HL, Oette K, Pulverer G, Roszkowski K, Uhlenbruck G,. Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D -galactose. J Cancer Res Clin Oncol 1987; 113: 51-5. (Pubitemid 17017567)
78. Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R,. Anti-galectin compounds as potential anti-cancer drugs. Curr Med Chem 2006; 13: 3513-27. (Pubitemid 44873744)
79. Oguchi H, Toyokuni T, Dean B, Ito H, Otsuji E, Jones VL, Sadozai KK, Hakomori S,. Effect of lactose derivatives on metastatic potential of B16 melanoma cells. Cancer Commun 1990; 2: 311-6. (Pubitemid 20380455)
80. Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB,. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Cancer Res 1996; 56: 5319-24. (Pubitemid 27011355)
81. Vrasidas I, Andre S, Valentini P, Bock C, Lensch M, Kaltner H, Liskamp RM, Gabius HJ, Pieters RJ,. Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors. Org Biomol Chem 2003; 1: 803-10.
82. Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL,. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis 2005; 26: 309-18. (Pubitemid 40246552)
83. Glinsky VV, Raz A,. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr Res 2009; 344: 1788-91.
84. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A,. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 2002; 94: 1854-62. (Pubitemid 36104630)